Innovid Price To Sales Ratio vs Days Sales Outstanding Analysis

CTV Stock

USD 3.01 1.39 85.80%

Innovid Corp financial indicator trend analysis is infinitely more than just investigating Innovid Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Innovid Corp is a good investment. Please check the relationship between Innovid Corp Price To Sales Ratio and its Days Sales Outstanding accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Innovid Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Innovid Stock please use our How to Invest in Innovid Corp guide.

Price To Sales Ratio vs Days Sales Outstanding

Price To Sales Ratio vs Days Sales Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Innovid Corp Price To Sales Ratio account and Days Sales Outstanding. At this time, the significance of the direction appears to have strong relationship.

The correlation between Innovid Corp's Price To Sales Ratio and Days Sales Outstanding is 0.63. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Days Sales Outstanding in the same time period over historical financial statements of Innovid Corp, assuming nothing else is changed. The correlation between historical values of Innovid Corp's Price To Sales Ratio and Days Sales Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Innovid Corp are associated (or correlated) with its Days Sales Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Sales Outstanding has no effect on the direction of Price To Sales Ratio i.e., Innovid Corp's Price To Sales Ratio and Days Sales Outstanding go up and down completely randomly.

Correlation Coefficient

0.63

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Innovid Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Innovid Corp sales, a figure that is much harder to manipulate than other Innovid Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Days Sales Outstanding

Most indicators from Innovid Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innovid Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Innovid Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Innovid Stock please use our How to Invest in Innovid Corp guide.Tax Provision is likely to climb to about 4.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 25.2 M in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	661K	5.6M	13.0M	13.6M
Interest Income	4.4M	13.3M	15.4M	16.1M

Depreciation And Amortization Interest Income

Innovid Corp fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Surpluse	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity
Total Assets		0.9	0.96	0.98	1.0	0.87	0.96	0.92	-0.42	-0.48	-0.96	0.71	0.68	0.87	0.89	0.87	0.71	0.94	0.86	-0.09	0.54	-0.95	0.96	0.85	0.85	1.0
Short Long Term Debt Total	0.9		0.95	0.87	0.86	0.62	0.86	0.94	-0.6	-0.13	-0.87	0.36	0.36	0.93	0.96	0.94	0.41	0.98	0.93	-0.07	0.6	-0.73	0.86	0.94	0.71	0.87
Other Current Liab	0.96	0.95		0.97	0.94	0.8	0.93	0.92	-0.41	-0.39	-0.94	0.56	0.6	0.86	0.9	0.91	0.63	0.99	0.85	-0.2	0.43	-0.86	0.93	0.87	0.83	0.95
Total Current Liabilities	0.98	0.87	0.97		0.98	0.9	0.96	0.89	-0.33	-0.55	-0.97	0.72	0.73	0.81	0.85	0.85	0.76	0.94	0.8	-0.18	0.38	-0.95	0.96	0.79	0.89	0.99
Total Stockholder Equity	1.0	0.86	0.94	0.98		0.89	0.95	0.9	-0.38	-0.53	-0.95	0.75	0.71	0.85	0.86	0.85	0.74	0.91	0.84	-0.07	0.53	-0.97	0.95	0.82	0.85	1.0
Other Liab	0.87	0.62	0.8	0.9	0.89		0.84	0.62	0.06	-0.85	-0.83	0.93	0.95	0.52	0.55	0.55	0.96	0.74	0.5	-0.4	0.25	-0.93	0.84	0.62	0.74	0.88
Net Tangible Assets	0.96	0.86	0.93	0.96	0.95	0.84		0.89	-0.48	-0.45	-1.0	0.7	0.66	0.83	0.87	0.83	0.69	0.93	0.82	-0.06	0.41	-0.94	1.0	0.79	0.85	0.96
Property Plant And Equipment Net	0.92	0.94	0.92	0.89	0.9	0.62	0.89		-0.69	-0.13	-0.9	0.39	0.35	0.98	0.99	0.99	0.39	0.93	0.98	0.19	0.56	-0.81	0.88	0.81	0.85	0.91
Current Deferred Revenue	-0.42	-0.6	-0.41	-0.33	-0.38	0.06	-0.48	-0.69		-0.54	0.48	0.19	0.33	-0.77	-0.75	-0.69	0.29	-0.51	-0.78	-0.65	-0.51	0.28	-0.48	-0.49	-0.4	-0.4
Net Debt	-0.48	-0.13	-0.39	-0.55	-0.53	-0.85	-0.45	-0.13	-0.54		0.44	-0.91	-0.96	0.0	-0.04	-0.05	-0.95	-0.29	0.01	0.56	0.08	0.65	-0.45	-0.19	-0.41	-0.51
Retained Earnings	-0.96	-0.87	-0.94	-0.97	-0.95	-0.83	-1.0	-0.9	0.48	0.44		-0.67	-0.65	-0.84	-0.88	-0.86	-0.68	-0.94	-0.83	0.07	-0.38	0.93	-1.0	-0.78	-0.88	-0.96
Accounts Payable	0.71	0.36	0.56	0.72	0.75	0.93	0.7	0.39	0.19	-0.91	-0.67		0.95	0.31	0.32	0.28	0.97	0.49	0.3	-0.36	0.24	-0.85	0.7	0.45	0.54	0.72
Cash	0.68	0.36	0.6	0.73	0.71	0.95	0.66	0.35	0.33	-0.96	-0.65	0.95		0.23	0.27	0.27	1.0	0.52	0.21	-0.55	0.05	-0.8	0.66	0.41	0.56	0.69
Non Current Assets Total	0.87	0.93	0.86	0.81	0.85	0.52	0.83	0.98	-0.77	0.0	-0.84	0.31	0.23		0.99	0.97	0.28	0.89	1.0	0.27	0.68	-0.74	0.83	0.84	0.75	0.86
Non Currrent Assets Other	0.89	0.96	0.9	0.85	0.86	0.55	0.87	0.99	-0.75	-0.04	-0.88	0.32	0.27	0.99		0.98	0.32	0.93	0.99	0.2	0.59	-0.75	0.87	0.84	0.8	0.88
Other Assets	0.87	0.94	0.91	0.85	0.85	0.55	0.83	0.99	-0.69	-0.05	-0.86	0.28	0.27	0.97	0.98		0.31	0.92	0.96	0.19	0.5	-0.74	0.83	0.78	0.85	0.87
Cash And Short Term Investments	0.71	0.41	0.63	0.76	0.74	0.96	0.69	0.39	0.29	-0.95	-0.68	0.97	1.0	0.28	0.32	0.31		0.55	0.26	-0.53	0.11	-0.82	0.69	0.46	0.57	0.72
Net Receivables	0.94	0.98	0.99	0.94	0.91	0.74	0.93	0.93	-0.51	-0.29	-0.94	0.49	0.52	0.89	0.93	0.92	0.55		0.88	-0.16	0.46	-0.82	0.93	0.89	0.8	0.92
Good Will	0.86	0.93	0.85	0.8	0.84	0.5	0.82	0.98	-0.78	0.01	-0.83	0.3	0.21	1.0	0.99	0.96	0.26	0.88		0.28	0.69	-0.73	0.82	0.84	0.74	0.85
Common Stock Shares Outstanding	-0.09	-0.07	-0.2	-0.18	-0.07	-0.4	-0.06	0.19	-0.65	0.56	0.07	-0.36	-0.55	0.27	0.2	0.19	-0.53	-0.16	0.28		0.21	0.06	-0.07	-0.21	0.13	-0.07
Short Term Investments	0.54	0.6	0.43	0.38	0.53	0.25	0.41	0.56	-0.51	0.08	-0.38	0.24	0.05	0.68	0.59	0.5	0.11	0.46	0.69	0.21		-0.41	0.4	0.76	0.14	0.5
Non Current Liabilities Total	-0.95	-0.73	-0.86	-0.95	-0.97	-0.93	-0.94	-0.81	0.28	0.65	0.93	-0.85	-0.8	-0.74	-0.75	-0.74	-0.82	-0.82	-0.73	0.06	-0.41		-0.94	-0.69	-0.86	-0.97
Capital Surpluse	0.96	0.86	0.93	0.96	0.95	0.84	1.0	0.88	-0.48	-0.45	-1.0	0.7	0.66	0.83	0.87	0.83	0.69	0.93	0.82	-0.07	0.4	-0.94		0.79	0.85	0.96
Capital Lease Obligations	0.85	0.94	0.87	0.79	0.82	0.62	0.79	0.81	-0.49	-0.19	-0.78	0.45	0.41	0.84	0.84	0.78	0.46	0.89	0.84	-0.21	0.76	-0.69	0.79		0.49	0.81
Other Current Assets	0.85	0.71	0.83	0.89	0.85	0.74	0.85	0.85	-0.4	-0.41	-0.88	0.54	0.56	0.75	0.8	0.85	0.57	0.8	0.74	0.13	0.14	-0.86	0.85	0.49		0.88
Other Stockholder Equity	1.0	0.87	0.95	0.99	1.0	0.88	0.96	0.91	-0.4	-0.51	-0.96	0.72	0.69	0.86	0.88	0.87	0.72	0.92	0.85	-0.07	0.5	-0.97	0.96	0.81	0.88

Click cells to compare fundamentals

Innovid Corp Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Innovid Stock Analysis

When running Innovid Corp's price analysis, check to measure Innovid Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovid Corp is operating at the current time. Most of Innovid Corp's value examination focuses on studying past and present price action to predict the probability of Innovid Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovid Corp's price. Additionally, you may evaluate how the addition of Innovid Corp to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Innovid Price To Sales Ratio vs Days Sales Outstanding Analysis

Price To Sales Ratio vs Days Sales Outstanding

Price To Sales Ratio vs Days Sales Outstanding Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Days Sales Outstanding

Innovid Corp fundamental ratios Correlations

Innovid Corp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Innovid Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Stockholder Equity
Capital Surpluse	+ 1.0	Net Tangible Assets
Cash And Short Term Investments	+ 1.0	Cash
Good Will	+ 1.0	Non Current Assets Total

Capital Surpluse	- 1.0	Retained Earnings
Retained Earnings	- 1.0	Net Tangible Assets
Other Stockholder Equity	- 0.97	Non Current Liabilities Total
Non Current Liabilities Total	- 0.97	Total Stockholder Equity
Retained Earnings	- 0.97	Total Current Liabilities
Other Stockholder Equity	- 0.96	Retained Earnings